Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer
2020 · Cancer Chemotherapy and Pharmacology · 70 citations
https://doi.org/10.1007/s00280-020-04168-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
480
Citations
10
h-index
10
i10-index
Zhen Zhang is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Extracellular vesicles in disease & Advanced biosensing and bioanalysis techniques & MicroRNA in disease regulation. The author has an h-index of 10, co-authored 13 publications.
ORCID: 0000-0002-4182-5629https://doi.org/10.1007/s00280-020-04168-z
https://doi.org/10.1016/j.isci.2025.112000
Click to start Chat